125 related articles for article (PubMed ID: 10846954)
1. [Transfusion-related hepatitis C. The Danish "look back" survey].
Christensen PB; Grønbaek KE; Krarup HB
Ugeskr Laeger; 2000 May; 162(18):2554-7. PubMed ID: 10846954
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
Christensen PB; Groenbaek K; Krarup HB
Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
[TBL] [Abstract][Full Text] [Related]
3. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
4. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C virus (HCV) status in recipients transfused with blood from anti-HCV-positive donors].
Riisom K; Møller A
Ugeskr Laeger; 1998 Mar; 160(11):1637-9. PubMed ID: 9522657
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C lookback programme: a single hospital experience.
Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
[TBL] [Abstract][Full Text] [Related]
7. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors.
Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF
QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
10. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
[TBL] [Abstract][Full Text] [Related]
11. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
[TBL] [Abstract][Full Text] [Related]
12. Recent Canadian experience with targeted hepatitis C virus lookback.
Goldman M; Patterson L; Long A
Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.
Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
N Engl J Med; 1992 Sep; 327(13):910-5. PubMed ID: 1325035
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
[TBL] [Abstract][Full Text] [Related]
16. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
17. [Natural clearance of hepatitis C virus in 96 patients with infection acquired by blood transfusion from a single donor in Guizhou].
Liu S; Cheng M; Mu M; Yang Q
Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):251-4. PubMed ID: 25173221
[TBL] [Abstract][Full Text] [Related]
18. HCV transmission through blood transfusion: are HCV-RNA titer in donor serum and genotype major determinants of infection outcome?
Cardoso MS; Koerner K; Epple S; Dengler T; Kerowgan M; Kubanek B
Beitr Infusionsther Transfusionsmed; 1996; 33():225-30. PubMed ID: 8865947
[TBL] [Abstract][Full Text] [Related]
19. [Detection of anti-HCV in blood recipients with hematonosis].
Liu J; Jiang TB; Wen F
Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):180-2. PubMed ID: 12934373
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C lookback in Canada.
Goldman M; Long A
Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
